| Biologic Therapy |
0 |
0.78 |
| Acute Leukemia |
0 |
0.71 |
| Non-Hodgkin Lymphoma (NHL) |
0 |
0.65 |
| Acute Myeloblastic Leukemia |
0 |
0.64 |
| Multiple Myeloma |
0 |
0.52 |
| Cancer |
0 |
0.51 |
| Leukemia |
0 |
0.46 |
| COVID-19 |
0 |
0.45 |
| Toxicology |
0 |
0.44 |
| Chronic Myelogenous Leukemia |
0 |
0.43 |
| Lymphoma |
0 |
0.43 |
| Acute Promyelocytic Leukemia |
0 |
0.42 |
| Chronic Lymphocytic Leukemia |
0 |
0.39 |
| Burkitt Lymphoma |
0 |
0.38 |
| Diffuse Large Cell Lymphoma |
0 |
0.36 |
| Genomic Medicine |
0 |
0.35 |
| Acute Lymphoblastic Leukemia |
0 |
0.34 |
| B-Cell Lymphoma |
0 |
0.34 |
| Social Determinants of Health |
0 |
0.34 |
| Follicular Lymphoma |
0 |
0.33 |
| Hodgkin Lymphoma |
0 |
0.32 |
| Socioeconomics |
0 |
0.26 |
| Blood |
0 |
0.2 |
| Stem Cell Research and Therapy |
0 |
0.16 |
| Clinical Research |
0 |
0.15 |
| Severe Acute Respiratory Syndrome |
0 |
0.13 |
| Texas |
0 |
0.13 |
| Acute Respiratory Distress Syndrome |
0 |
0.12 |
| Hematologic Malignancies |
0 |
1 |
| Cell Transplantation |
0 |
0.09 |
| Chemotherapy |
0 |
0.08 |
| Child |
0 |
0.08 |
| Mustard Vesicant |
0 |
0.08 |
| Prognosis |
0 |
0.08 |
| Racial and Ethnic Disparity |
0 |
1 |
| Revenue and Practice Management |
0 |
0.08 |
| Sleep |
0 |
0.08 |
| Transplantation |
0 |
0.08 |
| Tumor |
0 |
0.08 |
| CAR-T |
0 |
0.06 |
| Medical Life |
0 |
0.06 |
| Epidemiology |
0 |
0.05 |
| Face |
0 |
0.05 |
| Health Insurance |
0 |
0.05 |
| Insurance |
0 |
0.05 |
| Somatic |
0 |
0.05 |
| Bone Marrow |
0 |
0.04 |
| Monoclonal Gammopathies of Uncertain Origin |
0 |
0.04 |
| Racism in Medicine |
0 |
0.04 |
| Antigens |
0 |
0.03 |
| Bone |
0 |
0.03 |
| Breast |
0 |
0.03 |
| Clinical Guidelines |
0 |
0.03 |
| Europe |
0 |
0.03 |
| Genetics |
0 |
0.03 |
| Hematology |
0 |
0.03 |
| Hospital |
0 |
0.03 |
| Jobs |
0 |
0.03 |
| Monoclonal Gammopathy |
0 |
0.03 |
| Ohio |
0 |
0.03 |
| Plasma |
0 |
0.03 |
| Pollutant |
0 |
0.03 |
| Preventive Screening |
0 |
0.03 |
| Prostate |
0 |
0.03 |
| Racism |
0 |
0.03 |
| Receptors |
0 |
0.03 |
| Statistics |
0 |
0.03 |
| T-Lymphocyte |
0 |
0.03 |
| Young Adult |
0 |
0.03 |